GlassScriptPhysician profile
Aric A Wogsland
NPI 1649664822
$16,013.90
in general payments reported to CMS, 2019-2025
10 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,651 · 2021: $5,867 · 2022: $4,232 · 2023: $217 · 2024: $777 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256 · Travel and Lodging: $7.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.94 |
| Travel and Lodging | $7.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,571.11 | 2021-2025 | Endurant Iis, In.Pact Av |
| Medtronic Vascular, INC. | $4,651.46 | 2020 | |
| Silk Road Medical, INC. | $1,414.25 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $646.24 | 2022-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bard Peripheral Vascular, INC. | $429.74 | 2022-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Cook Medical LLC | $396.84 | 2022 | |
| Endologix LLC | $329.95 | 2022-2024 | |
| Abbott Laboratories | $285.10 | 2021 | |
| Shockwave Medical, INC | $176.77 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $112.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aric Wogsland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.